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Evaluation and Treatment of 




Elevated patient temperature is a common vital sign abnormality in the 
 emergency department that can be caused either by fever or hyperthermia. Fever is 
a frequent presentation, most commonly caused by infections of the respiratory or 
urinary tracts. Other occult sources include musculoskeletal, cardiac, neurological, 
and intra-abdominal infections. These infections can become complicated by sepsis 
and septic shock, conditions with high mortality. Treatment of the febrile acutely-ill 
patient should begin with fluids, antimicrobials, and source control. However, if 
this is ineffective or if the presentation is inconsistent with infection, consideration 
should be given to hyperthermia, rather than fever, being the cause of the patient’s 
elevated temperature. Several life-threatening and reversible conditions can mimic 
sepsis and present with elevated temperature. These mimics include toxicity from 
medications and illicit substances, neuroleptic malignant syndrome, malignant 
hyperthermia, and thyroid storm. Identification of these mimics as the source of 
elevated temperature can lead to earlier diagnosis and improved outcomes in these 
patients.
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1. Introduction: fever vs. hyperthermia
Elevated core body temperature is a common vital sign abnormality in the 
emergency department (ED) that can be caused by fever or hyperthermia. While 
both fever and hyperthermia describe a state of elevated core temperature, they 
are pathophysiologically distinct clinical entities with different underlying 
pathologies and treatments. Fever is defined as an elevated body temperature that 
occurs secondary to a normal thermoregulatory system functioning at a higher 
set point in response to a stimulus, most commonly infection or inflammation 
[1]. In contrast, hyperthermia causes elevated body temperature through  primary 
dysfunction of the hypothalamic thermoregulatory system itself [1]. Fever 
accounts for the vast majority of cases of elevated core temperature presentations 
in the ED, while hyperthermia is much more rare [1, 2]. Distinguishing between 
fever and hyperthermia may be difficult on initial patient presentation to the 
ED but the distinction has important implications for patient treatment and 
outcomes.
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2. Fever
Fever results from a pyrogen-mediated alteration in the set point of the 
thermoregulatory system in the anterior hypothalamus [1]. The interaction of 
endogenous and exogenous pyrogens with the hypothalamus results in increased 
production of prostaglandins, which act on temperature-sensitive neurons and 
lead to increased core temperature [1] Infection is the most common cause of 
fever, accounting for 74% of fevers in hospitalized patients [3]. Other processes 
that produce endogenous pyrogens, such as malignancy and ischemia, account 
for the majority of the  remaining sources of fever in hospitalized medical 
patients [4].
2.1 Sepsis
2.1.1 Definition of sepsis and septic shock
Despite significant emphasis by the Centers of Medicare and Medicaid 
Services (CMS) on the rapid identification and treatment of sepsis, there is no 
gold standard definition for the spectrum of sepsis syndromes. In actuality, sepsis 
is a complex and poorly understood process despite two centuries of research into 
its mechanisms. Sepsis is thought to result from a dysregulated and overexagger-
ated immune response to infection [5]. However, the complexity of sepsis and the 
variability in its presentation has thus far defied the creation of a gold standard 
definition, despite nearly three decades of attempts. The first definition of sepsis 
spectrum disorders was published in 1992 as a joint consensus statement between 
the American College of Chest Physicians (ACCP) and the Society of Critical 
Care Medicine (SCCM) [6]. This first consensus definition defined the presence 
sepsis spectrum disorders on elements of the patient’s systemic inflammatory 
response syndrome (SIRS) (Table 1) [6]. This definition had poor sensitivity 
and specificity for sepsis spectrum disorders, and multiple guidelines have since 
attempted to revise these initial definitions, with variable success in increasing 
the sensitivity and specificity. The most recent consensus definition, Sepsis-3, 
was published in 2016 by SSCM and the European Society of Intensive Care 
Medicine (ESCIM) and defined the sepsis spectrum disorders by the presence 
of infection and two or more elements of the quick Sequential Organ Failure 
Assessment (qSOFA) [7]. The Sepsis-3 consensus definitions are outlined in 
Table 2 below [7].
SIRS Two or more of the following:
Temperature > 38°C or < 36°C
Heart rate > 90 beats per minute
Respiratory rate > 20 breaths per minute or PaCO2 < 32 mmHg
White blood cell count >12,000 cu/mm, <4000 cu/mm, >10% bands
Sepsis Two SIRS criteria in the setting of known or suspected infection.
Severe 
sepsis
Sepsis and end-organ dysfunction
Septic 
shock
Sepsis with a systolic blood pressure < 90 mmHg or > 40 mmHg decrease in baseline systolic 
blood pressure
Table 1. 
Defining sepsis based on systemic inflammatory response syndrome (SIRS): Adapted from the 1992 ACCP/
SCCM consensus statement [6].
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2.1.2 Guidelines for the management of sepsis spectrum disorders
The Surviving Sepsis Campaign (SSC) guidelines offer recommendations 
for the resuscitation of patients with suspected sepsis spectrum disorders [8]. 
However, while these guidelines can provide an overview for the care of these 
patients, treatment should always be primarily guided by repeated clinical assess-
ment and reassessment of these patients. Current guidelines recommend the 
continuous administration of crystalloid fluids as long as hemodynamic factors 
continue to improve [8] If 30 ml/kg ideal body weight (IBW) balanced crystalloid 
fluids does not achieve a MAP ≥65 mm Hg, a vasoactive agent should be started 
[8]. Norepinephrine is currently the vasopressor of choice patients with septic 
shock [8]. The cornerstone of management of sepsis spectrum disorders is prompt 
source control through administration of antimicrobials or, if necessary, surgical 
intervention [8]. Cultures should be collected before the first dose of antimicrobial 
medications; culture collection should not delay source control interventions [8]. 
In the emergency department, early broad-spectrum antimicrobial therapy should 
be initiated based on the pathogen profile of the suspected site of infection, the 
patient’s prior culture results and susceptibilities, and local pathogen prevalence 
and resistance patterns. The spectrum of the antimicrobial agents can be narrowed 
as culture results become available or the patient presentation changes. Input from 
clinical pharmacists in the ED can assist in optimizing the initial antimicrobial 
choice and has been shown to decrease time to antibiotic administration, improve 
antibiotic stewardship, and improve patient outcomes [9–12].
2.2 Common sources: respiratory and urinary tract
Infections of the lower respiratory and urinary tracts comprise the majority of 
sepsis presentations to the ED. Community-acquired pneumonia (CAP) can be 
caused by a variety of bacterial and viral pathogens, with Strepotococcus pneumoniae 
being the most common bacterial etiology in those requiring hospitalization [13]. 
Other commonly implicated organisms include Haemophilus influenzae, Mycoplasma 
pneumoniae, and respiratory viruses. In patients requiring admission to a critical 
care unit, S. pneumoniae is still the most common etiologic organism but Legionella 
pneumophila, Staphylococcus aureus, gram-negative bacilli and influenza virus 
are more common [14]. Risk factors for drug resistance in CAP include age > 65, 
alcoholism, medical comorbidities, immunocompromise, immunosuppressive 
medication use, and use of beta-lactam, macrolide, or fluorquinolone antibiotics 
in the last 3–6 months [15]. Patients with hospitalization within three months have 
increased risk for hospital-acquired pneumonia with nosocomial organisms and 
their antibiotic regimens should include adequate coverage for Staphylococcus aureus 
and Psuedomonas auerginosa, which are more common in this population [15].
Infections of the urinary tract account for 40% of cases of nosocomial sepsis and 
the risk of infection is greatest in patients with structural or functional genitourinary 
abnormalities [16]. Sepsis from urinary source is more common in females [17]. 
qSOFA Altered mental status
Systolic blood pressure < 90 mmHg
Respiratory rate ≥ 22 breaths per minute
Table 2. 
Quick sequential organ failure assessment criteria (qSOFA) [7]: sepsis-3 defines sepsis as infection with two or 
more of the components listed below.
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Uncomplicated cystitis and pyelonephritis in women is typically caused by Escherichia 
coli, though Proteus mirabilis, Klebsiella pneumoniae, and Streptococcus saprophyticus 
are also relatively common [18]. As such, empiric treatment for uncomplicated 
urinary tract infections is best tailored to the regional E. coli sensitivities [18]. A 
complicated urinary tract infection is one which is associated with a condition that 
increases the risk for therapeutic failure [19]. These risk factors include diabetes, 
pregnancy, ureterolithiasis, renal failure, >7 days of symptoms, or an indwelling 
urinary device [19]. The microbial spectrum of complicated UTI is more varied and 
includes not only the typical organisms associated with uncomplicated UTI but also 
Pseudomonas, Staphylococcus, and Serratia species as well as fungi [19]. Complicated 
lower urinary tract infections may be managed as an outpatient; indications for 
hospitalization include inability to tolerate oral therapy or suspected infection with 
an organism resistant to oral therapies, such as extended-spectrum beta-lactamase 
producing organisms (ESBLs) [19].
2.3 Musculoskeletal
A comprehensive physical examination is of utmost importance in patients with 
a potential musculoskeletal infection as laboratory evaluation in these patients 
is generally non-diagnostic. Poor circulation and neuropathy are important risk 
factors for the development of musculoskeletal infections, and, as such, patients 
may not be able localize the source of their infection. Examination should include 
turning the patient to examine the back, palpation of the large joints, and exami-
nation of the feet and genitourinary regions for skin changes, which are often 
the only clue to the presence of a musculoskeletal infection [20, 21]. Comparison 
with the contralateral side can help to provide a baseline with which to compare 
for abnormalities. Practitioners should also evaluate for the presence of decubitus 
ulcers, which can become a nidus for osteomyelitis or bacteremia. Crepitus or pain 
out of proportion to examination should prompt concern for necrotizing soft tissue 
infection. Erythema, swelling, or pain with passive motion in a joint are concerning 
for a septic joint, with the knee and hip being the most common sources [22]. Risk 
factors for musculoskeletal infections include vasculopathy, diabetes, surgery, and 
immunocompromise [20]. Staphylococcus aureus or Streptococcus pyogenes-associated 
cellulitis is the most common cause of sepsis secondary to musculoskeletal infection 
[20]. While magnetic resonance imaging (MRI), surgical pathology, or culture is 
often necessary for the definitive diagnosis of most musculoskeletal infections, this 
should not delay early and aggressive source control in the ED.
2.4 Cardiac
Infectious pericarditis, myocarditis, and endocarditis as causes of sepsis can 
be easily missed in the emergency department due to their often subtle and vari-
able presentations. Acute infectious pericarditis describes infection of the fibrous 
tissue encasing the heart and the base of the aorta and vena cava. Echoviruses and 
coxsackie A and B viruses account for nearly 90% of cases of infective pericarditis, 
with bacterial, parasitic, and fungal organisms accounting for the minority of cases 
[23]. The most common bacterial pathogens implicated in infective pericarditis 
are Streptococcus pneumoniae and Staphylococcus auresus [23]. The diagnosis of 
acute pericarditis is based on the presence of characteristic chest pain and elec-
trocardiographic abnormalities [23]. Auscultation of a friction rub is helpful but 
is poorly sensitive for the diagnosis [24]. Infective myocarditis describes infection 
of the myocardial tissue, with coxsackie B being the most common cause. Other 
common causes include influenza virus, adenovirus, hepatitis C virus, parvovirus 
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B-19, and cytomegalovirus [23]. Infectious myocarditis should be considered in 
patients presenting with chest pain and signs of heart failure, especially when there 
is concurrent fever. Finally, the presence of a new murmur in an acutely ill patient 
should raise suspicion for infective endocarditis (IE), infection of endocardial lin-
ing of the heart valves. Important risk factors for endocarditis include intravenous 
drug use, prosthetic valves, indwelling intravascular devices, and immunocompro-
mise [25]. IE presents remarkably variably and symptoms depend on the stage of 
disease. Fever is the most common symptom of IE; other findings concerning for 
endocarditis include stigmata of peripheral thromboembolism such as Osler nodes, 
Janeway lesions, Roth spots, or splinter hemorrhages [25]. Patients with IE may also 
present initially with complications of endocarditis, which include cerebrovascular 
ischemia or hemorrhage, septic emboli, and metastatic infection.
2.5 Meningitis and encephalitis
Meningitis is an infection of the meningeal lining of the central nervous system 
by bacteria, viruses, or fungi, with bacterial causes accounting the highest global 
burden [26]. Encephalitis describes infection of the cerebral parenchyma with a 
pathogen. Streptococcus pneumonia, group B streptococci, and Neisseria meningitidis 
are the most common causes of bacterial meningitis, with Listeria monocytogenes 
also being common in children, immunocompromised individuals, and adults 
greater than 50 years of age [26, 27]. Common viral causes of meningitis and 
encephalitis include herpesviruses, enteroviruses, and cytomegalovirus [28]. Fever, 
altered mental status, and nuchal rigidity are the classically described triad of 
meningitis, but the majority of patients in clinical practice only manifest one or two 
of these symptoms [26]. Lumbar puncture with cerebrospinal fluid (CSF) analysis 
is the diagnostic test of choice for meningitis. CT imaging should precede lumbar 
puncture in patients whose symptoms may be secondary to mass effect, such as 
those with immunocompromise, new seizure, papilledema, focal neurologic deficit, 
or altered mental status [26, 28, 29] Importantly, diagnostic studies should not 
delay the administration of antimicrobials in patients with suspected meningitis or 
encephalitis. Administration of antimicrobials prior to lumbar puncture has been 
shown to have minimal effect on chemistry and cytology findings studies of CSF 
but may lead to a falsely negative Gram stain or culture [30–32]. This should not 
affect the decision to start empiric antibiotics early in these patients.
2.6 Spinal column infections
Infections of the spinal column are an important diagnostic consideration in all 
patients presenting to the ED with back pain. Potential sources of infection in the 
spinal column include vertebral osteomyelitis, discitis, and epidural abscess. These 
infections are commonly missed, as there is remarkable variability in patient pre-
sentation and fever is seen in only half of these patients [33–35] Neurologic deficits 
likewise may or may not be present [33–35]. Risk factors for infections of the spinal 
column include immunocompromise, recent instrumentation, spinal implants, and 
use of intravenous drugs [35]. Magnetic resonance imaging (MRI) is the preferred 
imaging study in patients with suspected spinal column infection [35]. If MRI is 
unavailable, CT myelography can also be used [35].
2.7 Intraabdominal infections
Causes of intraabdominal sepsis include abdominal and pelvic abscesses, 
pelvic inflammatory disease, spontaneous bacterial peritonitis, cholecystitis or 
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cholangitis, ruptured hollow viscus, or infection of the gastrointestinal tract. While 
abdominal sources for sepsis are common in the ED, the diagnosis may be hampered 
by examination difficulties secondary to the patient’s mental status or body habitus. 
Altered consciousness can impede a patient’s ability to localize their discomfort, and 
many abdominal pathologies have no manifestations on external visual examina-
tion. As such, a thorough abdominal examination is of vital importance in altered 
patients. Although these patients may be unable to verbalize discomfort, absent 
bowel sounds, abdominal distention, or abdominal rigidity on examination can be 
clues to the presence of intraabdominal pathology [36–38]. Additionally, grimac-
ing, guarding, or reflex tachycardia can be useful indicators of pain in patients are 
altered or obtunded [36–38]. Pelvic examination should be done if a pelvic source 
is suspected or if there is concern for toxic shock syndrome secondary to a retained 
vaginal foreign body [38].
2.8 Indwelling devices
Indwelling devices such as urinary catheters, ports, pacers, and long-term intra-
venous access are associated with an increased risk of infection. Examination of 
these devices is an important part of the physical examination of the septic patient. 
Erythema or purulence at the exit site is specific for infection but these signs of 
not sensitive for the presence of device-associated infection. In fact, less than 5% 
of dialysis line-associated bacteremia was found to have associated purulent exit 
site drainage [39]. Because physical examination findings are often absent, it is 
important to keep device-associated infection in the differential in septic patients. 
If infection is suspected, the device should be removed as soon as clinically possible 
and cultured [39–41].
3. Hyperthermia
While a reflexive diagnosis of sepsis is tempting for the ill-appearing patient 
with an elevated temperature, it is important to consider conditions that mimic 
sepsis which are often both life-threatening and reversible. Unlike the fever associ-
ated with sepsis, the majority of these sepsis mimics have elevated temperature as 
a result of hyperthermia, which occurs secondary to dysfunction of the hypotha-
lamic thermoregulatory system [1]. If an infectious source cannot be found in a 
seemingly septic patient or the patient is not improving with antibiotics and fluids, 
it is important to broaden the differential to conditions that cause hyperthermia 
(Table 3).
3.1 Neuroleptic malignant syndrome (NMS)
NMS is a life-threatening syndrome of altered mental status, autonomic insta-
bility, hyperthermia, and muscle rigidity associated with the use of dopaminergic 
antagonists. “Lead pipe” rigidity is the hallmark physical examination finding in 
NMS and can be severe enough to precipitate rhabdomyolysis. Most commonly, 
NMS occurs with the use of dopaminergic antagonists used in the treatment of 
psychiatric disorders and nausea, but NMS can also be precipitated by may be caused 
withdrawal from dopaminergic medications, such as those used in the treatment of 
Parkinson’s disease [42, 43]. First generation antipsychotic medications are the most 
commonly implicated in NMS, with haloperidol and fluphenazine having the highest 
risk [42]. Risk factors for the development of NMS include higher medication doses, 
recent or rapid dose escalation, and parenteral medication administration [42]. 
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The highest risk of NMS is within two weeks of medication initiation but this 
syndrome develop at any time during the treatment timeline [44]. A review of the 
patient’s medications is typically needed to make the diagnosis. The cornerstone of 
management of NMS is supportive, with discontinuation of the suspected offend-
ing agent, support of the cardiopulmonary system, maintenance of normothermia 
and euvolemia, and prevention of complications including deep venous thrombosis, 
acute renal failure, and cardiac dysrhythmias [42–44]. In cases of severe muscle 
rigidity not responding to supportive treatment, intravenous dantrolene sodium or 
oral bromocriptine mesylate should be considered [44].
3.2 Serotonin syndrome (SS)
SS is a syndrome of altered mentation, neuromuscular abnormalities, and auto-
nomic hyperactivity caused by excess serotonin levels [45]. The most commonly 
implicated medications in SS include linezolid, fentanyl, and selective serotonin 
reuptake inhibitor (SSRIs) [46]. The neuromuscular abnormalities associated with 
SS can include hyperreflexia, clonus, or muscle rigidity, and, as with NMS, these 
may be severe enough to which may lead to rhabdomyolysis [45, 46]. SS is a clinical 
diagnosis based on patient presentation, and there is no laboratory test or imaging 
study to confirm the diagnosis [45]. The Hunter criteria for serotonin syndrome 
is one outline the clinical criteria needed to make the diagnosis [47]. Like NMS, 
management of SS is primarily supportive. If this is insufficient or ineffective, 
use of cyproheptadine can be used under the consultation of a toxicologist [45]. 
If neuromuscular paralysis is need to control neuromuscular rigidity or facilitate 
intubation, only nondepolarizing agents should be used, as depolarizing agents 
may exacerbate the hyperkalemia precipitated by the neuromuscular abnormalities 












Malignant hyperthermia Hyperthermia, tachycardia, 
hypercarbia, muscle rigidity in 
the setting of volatile anesthetic or 
depolarizing muscle relaxants
Dantrolene sodium, cooling 
measures, treatment of 
hyperkalemia
Salicylate toxicity Delirium, hyperthermia, tachycardia, 
hyperpnea, gastrointestinal irritation, 
tinnitus, triple acid–base disturbance
Sodium bicarbonate
Anticholinergic toxicity Delirium, tachycardia, dilated 
nonreactive pupils, urinary retention, 
anhidrotic hyperthermia
Supportive
Sympathomimetic toxicity or 
withdrawal from sympathetic 
antagonists
Delirium, tachycardia, hyperthermia, 
hypertension, dilated reactive pupils
Benzodiazepines
Thyroid storm Tachycardia, hyperthermia, agitation, 
lid-lag, ophthalmopathy, hand tremor.
Beta-blocker, thionamide, 
steroids
Non-exertional heat stroke Fever, tachycardia, neurologic 
manifestations
Evaporative and convective 
cooling
Table 3. 
Hyperthermic sepsis mimics, their presentation, and their management.
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Suspect serotonin syndrome if the patient has taken a serotonergic agent and has 
one of the symptom complexes outlined below (Table 4).
3.3 Malignant hyperthermia (MH)
MH is a genetic disorder which results in a hypermetabolic response to volatile 
anesthetics and depolarizing muscle relaxants [48]. This pathologic response to 
these medications results from caused the release of excessive calcium from the sar-
coplasmic reticulum, which leads to uncoupling of oxidative phosphorylation, the 
release of heat, and a rise in metabolic rate [49]. MH presents with hyperthermia, 
tachycardia, hypercarbia, increased oxygen consumption, and muscle rigidity fol-
lowing the administration of a volatile anesthetic or depolarizing muscle relaxants. 
In the ED, MH is most likely to present following an intubation using succinylcho-
line and MH should be a diagnostic consideration in a patients with acute decom-
pensation following intubation. MH is treated with intravenous dantrolene loaded 
at a dose of 2.5 mg/kg followed by boluses of 1 mg/kg until symptoms resolution 
[48]. Aggressive cardiopulmonary support, maintenance of normothermia and 
euvolemia, and treatment of electrolyte derangements is likewise important.
3.4 Salicylate toxicity
Aspirin ingestion is the most common cause of salicylate toxicity, but other 
common sources include Oil of Wintergreen, some wart removers, and keratolytics 
[50]. Salicylate toxicity is an important sepsis mimic, as patients with salicylate 
toxicity will have tachycardia, tachypnea, elevated temperature, and lactic aci-
dosis. These symptoms occur secondary to salicylate interference with aerobic 
metabolism [50]. The classically described triad of salicylate toxicity is hyperpnea, 
tinnitus, and gastrointestinal irritation [51]. Gastrointestinal symptoms vary and 
can include abdominal pain, nausea, vomiting, and diarrhea. Tinnitus associated 
with salicylate toxicity may be described as hearing loss rather than “ringing in the 
ears” by patients and may be a difficult symptom to elicit if the patient is altered or 
obtunded [51]. Laboratory testing in salicylate toxicity will show a classic “triple 
acid-base disorder.” This includes a respiratory alkalosis from hyperventilation, a 
compensatory non-gap metabolic acidosis, and an anion-gap metabolic acidosis 
from secondary to lactic acid accumulation [51]. Management is through systemic 
alkalinization with sodium bicarbonate [52].
3.5 Anticholinergic toxicity
Anticholinergic substances are ubiquitous in both pharmaceutical compounds 
and nature. Commonly encountered causes of anticholinergic toxicity include 
ingestion of antihistamine medications, tricyclic antidepressants, jimson weed, and 
tainted recreational drugs. Anticholinergic toxicity can easily be mistake for sepsis, 
Spontaneous clonus
Inducible clonus AND agitation OR diaphoresis
Ocular clonus AND agitation OR diaphoresis
Tremor AND hyperreflexia
Hypertonia, temperature > 38°C AND ocular OR inducible clonus
Table 4. 
Hunter criteria for serotonin syndrome [47].
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as these patients present with high temperature, delirium, and tachycardia [53]. 
A distinguishing feature of anticholinergic toxicity is the presence of anhidrotic 
hyperthermia, in contrast to septic patients who are febrile and diaphoretic [53]. 
This is a result of anticholinergic blockade of sweat glands, preventing homeostatic 
hydrosis in response to elevated core temperature [53, 54]. Other clinical findings 
in anticholinergic toxicity include dry mucus membranes, dilated, non-reactive 
pupils and urinary retention [53]. The management of anticholinergic toxicity is 
primarily supportive. Benzodiazepines should be used for agitation or seizures 
[54]. Physostigmine, an anticholinesterase inhibitor, can be used as an antidote for 
anticholinergic toxicity under the consultation of a toxicologist [54].
3.6 Sympathomimetic toxicity or withdrawal from sympathetic antagonists
Overstimulation of the sympathetic nervous system can occur through direct 
agonism of the sympathetic receptors or withdrawal from substances that act as 
sympathetic antagonists [55]. Common sympathomimetic compounds encountered 
in the ED include cocaine, phencyclidine, and amphetamines. Withdrawal from 
alcohol or benzodiazepines can also result in sympathetic overstimulation [56]. 
Symptoms of sympathomimetic toxicity hyperthermia, tachycardia delirium, and 
reactive mydriasis [55]. Hyperthermia in sympathetic overstimulation results from 
direct agonism of alpha receptors as well as heat released by associated psychomotor 
agitation [55]. Benzodiazepines are mainstay of management of both sympathomi-
metic toxicity and withdrawal from antisympathetic agents [55].
3.7 Thyroid storm
Thyroid storm is the most severe manifestation of thyrotoxicosis and can be 
caused by overdose of therapeutic thyroid hormone or may present in patients 
with underlying thyrotoxicosis, seemingly unprovoked or may be precipitated by 
trauma, infection, childbirth, or other acute events [57]. Symptoms of thyroid 
storm include delirium, hyperthermia, diarrhea, and tachydysrhythmias, which can 
be severe enough to cause cardiovascular collapse and hemodynamic compromise 
[57, 58]. Liver failure may also occur [57]. The diagnostic laboratory abnormality in 
thyroid storm a severely low or undetectable thyroid stimulating hormone (TSH). 
Physical examination findings concerning for thyroid storm are those classically 
seen in hyperthyroidism and include ophthalmopathy, lid lag, thyromegaly, hand 
tremor, and global hyperreflexia [57, 58]. ED management of includes immediate 
treatment with a beta blocker, a thionamide, and glucocorticoids [59]. An iodine 
preparation should be given an hour after the administration of the thionamide, 
to prevent the iodine being used as substrate for the synthesis of more thyroid 
hormone [59]. If an infection is suspected as the cause of thyroid storm, broad-
spectrum empiric antibiotics should be administered.
3.8 Heat stroke
Heat stroke is condition of elevated core body temperature with associated 
central nervous system dysfunction, commonly encephalopathy [60]. Heat stroke 
can be broadly divided into non-exertional and exertional. Non-exertional heat 
stroke classically affects older individuals with comorbidities that result in impaired 
thermoregulation, prevent access to adequate hydration, or inhibit removal from a 
hot environment [60]. In contrast, exertional heat stroke is more likely to occur in 
young, healthy individuals in the setting of exertion that overwhelms homeostatic 
thermoregulatory mechanisms. Heat stroke is a clinical diagnosis of exclusion made 
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based on elevated body temperature (generally >40°C), central nervous system 
dysfunction (classically encephalopathy), and a history of exposure to severe 
environmental heat or excessive exertion [60]. Evaporative and convective cooling 
are the treatments of choice and should be initiated as soon as the diagnosis is made 
to improve morbidity and mortality [61, 62]. Common cooling methods used in 
the ED include ice water immersion, cooled fluid lavage, and evaporative cooling 
[61, 62]. In cases of refractory hyperthermia, dantrolene can be used as salvage 
therapy but its efficacy in this clinical context is uncertain [63, 64].
4. Conclusion
Elevated core temperature can be the result of either fever or hyperthermia. 
Fever is mor common and is typically caused by infections of the respiratory 
or urinary tracts. Other potential sources of infection include musculoskeletal, 
cardiac, neurological, and intra-abdominal as well as infection from indwelling 
medical devices. Treatment of patients with elevated core temperature should begin 
with fluids, empiric antimicrobials, and source control. If treatment of infection 
is ineffective or if the presentation is inconsistent with the presence of infection, 
the differential diagnosis should be expanded to consider conditions that cause 
hyperthermia as the cause of elevated core temperature. Such sepsis mimics include 
toxicity from medications and illicit substances, neuroleptic malignant syndrome, 
serotonin syndrome, malignant hyperthermia, thyroid storm, and heat stroke. 
Identification of these mimics as the source of elevated temperature leads to earlier 
diagnosis and improved prognosis in these patients.
© 2020 The Author(s). Licensee IntechOpen. This chapter is distributed under the terms 
of the Creative Commons Attribution License (http://creativecommons.org/licenses/
by/3.0), which permits unrestricted use, distribution, and reproduction in any medium, 
provided the original work is properly cited. 
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